Rapid reinsurance dealmaking is here with hyperexponential and Supercede partnership

hyperexponential and Supercede have brought their SaaS platforms together to reimagine and reinvigorate reinsurance dealmaking, enabling reinsuers to create, validate, broker, and quote treaty submissions in 29 minutes instead of 12 weeks.

hyperexponential and Supercede have brought their SaaS platforms together to reimagine and reinvigorate reinsurance dealmaking. Hampered by poor data practises by insurers, reinsurers have been widely neglected by insurtechs due to the need for complex structures and models using disparate and specific datasets. Now, they finally have 21st century tools to price today’s emerging risks. 

Amrit Santhirasenan, Co-Founder & CEO of hyperexponential said “We’re putting the power back in the hands of practitioners! Renew has always linked to underwriters and actuaries’ internal systems and databases, but by linking in with industry-wide platforms like Supercede, we can supercharge our productivity gains and push them right up and down the value-chain.”

The proof is in the pudding: multi-month to multi-hour

Using standardised underlying risk information, Supercede’s reinsurance platform rapidly creates a digital cedent submission pack and instantly attaches this to deal data for onward transmission to markets. This accelerates the process used by cedents and brokers in today’s market, cutting a three month submission preparation period down to just a few hours.

Unifying pricing actuaries and brokers: from prep to quote in minutes

This same deal and risk information is then extracted from Supercede’s reinsurance platform to be instantly ingested into the Renew platform. Renew is able to use custom pricing models built on the platform by real pricing actuaries to take this risk and deal information and provide a rapid quotation back to the broker in less than 30 minutes.

Jerad Leigh, Co-Founder & CEO of Supercede said “We’re excited to successfully prove out what the market has been telling us is possible for years. With reinsurers using automated actuarial pricing systems like Renew, and cedents and brokers using Supercede to build, collaborate and share their deals, we can turn a clunky, multi-month process into something expertly executed in under a few hours. This leaves precious time to add real value to the relationships and entrepreneurism that makes this market so great.”

The future of reinsurance deals is here

As with insurers, reinsurers must modernise their processes, replacing spreadsheets from 1997 with modern technology capable of analysing vast datasets that can give them a competitive edge. hyperexponential and Supercede have proven how quickly treaty reinsurance submissions can be created, validated, brokered and quoted if the right tools are put in place. In addition to improving productivity from a time perspective, this tech also improves accuracy of risk pricing thereby reducing your loss ratio. 

About hyperexponential

We’ve reimagined the actuarial pricing system from the ground up. By combining actuarial knowledge and technical expertise, we’ve targeted the issues you face day-to-day. The result is Renew - a web-based SaaS platform that’s custom-built for the small, sparse and fragmented datasets that dominate the working life of our clients.

A first for the industry, Renew empowers your team by making it simple for anyone to build and adapt models quickly. It automates non-core but essential activities and brings actuaries and underwriters closer together. Super-fast and agile, it puts best practice pricing and modelling at your fingertips so you can focus on analysis and being your most productive self.

About Supercede

Supercede’s global reinsurtech platform is here to help you manage any kind of reinsurance deal so you look great to your partners and customers, enabling you to be more profitable and grow faster. Supercede supports the entire reinsurance value chain of cedents who want better submission quality, brokers who want a better placement process, and reinsurers who want better access to risks and data.